[1] LokASF , LaiCL .α-fetoproteinmonitoringinChinesepatientswithchronichepatitisvirusinfection∶roleintheearlydetectionofhepatocellu alrcarcinoma[J].Hepatology, 1989, 9 (1) ∶110-115.
|
[2] 中华医学会传染与寄生虫病学分会, 肝病学分会病毒型肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) ∶56-62.
|
[3] LiawYF , TaiDI, ChenTJ , etal.Alpha-fetoproteinchangesinthecourseofchronichepatitis∶relationtobridginghepaticfibrosisandhepatocellularcarcinoma[J].Liver, 1986, 6 (3) ∶133-137.
|
[4]贾克东, 石淑仙, 林剑国, 等肝硬化患者肝脏炎症对AFU诊断肝癌价值的影响[J].肿瘤防治杂志, 2003, 10 (4) ∶379-382
|
[5]贾克东, 石淑仙, 阮幼冰血清标志物在肝炎肝硬化患者中诊断肝癌的价值[J].胃肠病学和肝脏学杂志, 2004, 13 (1) ∶58-62
|
[6] AkcayF , TaysiS , UsluC , etal.Levelsofsolubleintercellularadhesionmolecule-1andtotalsialicacidinserumofpatientswithlaryngealcan cer[J].JpnJClinOncol, 2001, 31 (12) ∶584-588.
|
[7] Ros-BullonMR , Sanchez-PedrenoP , Martinez-LiarteJH , etal.Serumsialicacidinmalignantmelanomapatients∶anROCcurveanalysis[J].AnticancerRes, 1999, 19 (4C) ∶3619-3622.
|
[8] FeijooC , PaezdelaCadenaM , Rodriguez-BerrocalFJ , etal.Sialicacidlevelsinserumandtissuefromcolorectalcancerpatients[J].CancerLett, 1997, 112 (2) ∶155-160.
|
[9] TewarsonSL , MittalVP , SinghM , etal.Serumsialicacid-animportantcancermarker[J].IndianJCancer, 1993, 30 (3) ∶125-131.
|
[10]叶振武, 潘爱娟, 李朋, 等血清唾液酸检测对原发性肝癌的诊断意义[J].临床肝胆病杂志, 2003, 19 (4) ∶247-248.
|
[1] | Xiwang WANG, Jingjing JIN, Ying WANG, Chenxiao WANG, Yonghua ZHANG, Yajiao GU, Xiao WANG. Pathogenesis, diagnosis, and treatment of pancreatogenic diabetes[J]. Journal of Clinical Hepatology, 2024, 40(5): 1068-1072. doi: 10.12449/JCH240532 |
[2] | Ruibin WANG, Yuzheng LU, Jinglin ZHU, Wei WANG, Guang JIA. Inhibitory effect of lidocaine on Kupffer cell inflammatory response and its effect on liver abscess formation in diabetic mice[J]. Journal of Clinical Hepatology, 2022, 38(6): 1341-1346. doi: 10.3969/j.issn.1001-5256.2022.06.023 |
[3] | Deyun WANG, Ruirui JIN, Zhen ZHAO, Hui LI. Brain abscess secondary to liver abscess in type 2 diabetes mellitus: A case report[J]. Journal of Clinical Hepatology, 2022, 38(6): 1375-1376. doi: 10.3969/j.issn.1001-5256.2022.06.031 |
[4] | Changqing ZHAO. Integrated traditional Chinese and Western medicine diagnosis and treatment of liver cirrhosis with diabetes[J]. Journal of Clinical Hepatology, 2022, 38(9): 1980-1985. doi: 10.3969/j.issn.1001-5256.2022.09.006 |
[5] | Zhao Juan, Hui Wei, Dou AiHua, Wei LinLin, Liu Mei, Dong GuiFang, Xu Bin. A clinical analysis of hypoglycemia in patients with liver cirrhosis and diabetes mellitus[J]. Journal of Clinical Hepatology, 2020, 36(2): 329-332. doi: 10.3969/j.issn.1001-5256.2020.02.019 |
[6] | Zhang YongChao, Li Wei. Association between diabetes and nonalcoholic fatty liver disease-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(10): 2329-2332. doi: 10.3969/j.issn.1001-5256.2020.10.037 |
[7] | Wang WeiZhao, Zhu QinLing, Xiang XiaoXing, Ma Li, Ju MengXian, Jin XiaoLong, Wang YongChao, Han WeiWei, Xu QingCheng. Clinical features of diabetic patients with bacterial liver abscess and different levels of glycosylated hemoglobin[J]. Journal of Clinical Hepatology, 2019, 35(11): 2537-2541. doi: 10.3969/j.issn.1001-5256.2019.11.029 |
[8] | Zhang ShuZe, Wang KeShen, Ren YanXian, Yu ZeYuan, Yang HanTeng, Jiao ZuoYi. Clostridium perfringens liver abscess in patients with diabetes mellitus: A case report[J]. Journal of Clinical Hepatology, 2018, 34(9): 1979-1981. doi: 10.3969/j.issn.1001-5256.2018.09.030 |
[9] | Yang Shuo, Jiang XiaoDi. Clinical effect of linagliptin combined with insulin aspart 50 in treatment of hepatogenous diabetes[J]. Journal of Clinical Hepatology, 2017, 33(5): 928-931. doi: 10.3969/j.issn.1001-5256.2017.05.028 |
[10] | Liang Jing, Han Tao. Diabetes mellitus and primary liver cancer: risk factor or real cause?[J]. Journal of Clinical Hepatology, 2017, 33(4): 757-762. doi: 10.3969/j.issn.1001-5256.2017.04.037 |
[11] | Wang LiFeng, Li YuanYuan, Jin Lei, Wang FuSheng. Epidemiology and natural history of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 165-170. doi: 10.3969/j.issn.1001-5256.2015.02.005 |
[12] | Liu HongXia, Cheng Min, Wang XiMing, Lei Ding. Clinical effect of combination therapy with NovoRapid 30 and modified Yinchenhao decoction in treatment of chronic hepatitis B with diabetes[J]. Journal of Clinical Hepatology, 2014, 30(4): 311-313. doi: 10.3969/j.issn.1001-5256.2014.04.006 |
[13] | Hui Wei, Xu Bin, Guo XinHui. Clinical study on glucose metabolic disorder in patients with diabetes and chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2012, 28(7): 538-541. |
[14] | Zhao ZhangQing, Gu HongTu, Xing Feng, Zhou Yang, Xu LieMing. Clinical features of post-hepatitis B liver cirrhosis associated with diabetes mellitus[J]. Journal of Clinical Hepatology, 2012, 28(6): 450-455. |
[15] | Zhang FengChun. Primary biliary cirrhosis and liver disease secondary to diffuse connective tissue diseases[J]. Journal of Clinical Hepatology, 2011, 27(6): 588-590. |
[16] | Yu MingXia, Yin WeiMin, Li YingJin, Wu Yang. The treatment status of hepatogenous diabetes[J]. Journal of Clinical Hepatology, 2011, 27(7): 779-782. |
[20] | Qin YingFen, Xian Su, Wei MinYi, Luo ZuoJie, Chen QingYun, Wang NaiZun. Changes of hepatic ultrastructure in patients with diabetes mellitus[J]. Journal of Clinical Hepatology, 2000, 16(4): 241-243. |